Cargando…

The Therapeutic Effects of EFNB2-Fc in a Cell Model of Kawasaki Disease

The EphrinB2/EphB4 signaling pathway involves the regulation of vascular morphogenesis and angiogenesis. However, little is known about EphrinB2/EphB4 in the pathogenesis of Kawasaki disease (KD) and coronary artery aneurysm formation. Hence, this study aimed to explore the role of EphrinB2/EphB4 an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Yijing, Wang, Wei, Jin, Yihua, Wang, Min, Xu, Jiawen, Wang, Yujia, Gong, Fangqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142267/ https://www.ncbi.nlm.nih.gov/pubmed/37111257 http://dx.doi.org/10.3390/ph16040500

Ejemplares similares

The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease
por: Qi, Yanqi, et al.
Publicado: (2021)

Analysis of the association of EPHB6, EFNB1 and EFNB3 variants with hypertension risks in males with hypogonadism
por: Wu, Tao, et al.
Publicado: (2018)

KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease
por: Zheng, Fenglei, et al.
Publicado: (2021)

Crucial transcripts predict response to initial immunoglobulin treatment in acute Kawasaki disease
por: Geng, Zhimin, et al.
Publicado: (2020)

Altered Monocyte Subsets in Kawasaki Disease Revealed by Single-cell RNA-Sequencing
por: Geng, Zhimin, et al.
Publicado: (2021)

The role of Ca(2+)/NFAT in Dysfunction and Inflammation of Human Coronary Endothelial Cells induced by Sera from patients with Kawasaki disease
por: Wang, Ying, et al.
Publicado: (2020)

The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury
por: Gao, Lichao, et al.
Publicado: (2023)

The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease
por: Sun, Yameng, et al.
Publicado: (2020)

A new model to predict intravenous immunoglobin-resistant Kawasaki disease
por: Hua, Wang, et al.
Publicado: (2017)

The effect of conditional EFNB1 deletion in the T cell compartment on T cell development and function
por: Jin, Wei, et al.
Publicado: (2011)

Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
por: Xie, Tian, et al.
Publicado: (2017)

Notch4 signaling pathway in a Kawasaki disease mouse model induced by Lactobacillus casei cell wall extract
por: Gao, Lichao, et al.
Publicado: (2017)

Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene
por: Tremblay, Johanne, et al.
Publicado: (2017)

Similarities and differences between MIS-C and KD: a systematic review and meta-analysis
por: Tong, Tong, et al.
Publicado: (2022)

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease
por: Qi, Yanqi, et al.
Publicado: (2012)

The impact of CFNS-causing EFNB1 mutations on ephrin-B1 function
por: Makarov, Roman, et al.
Publicado: (2010)

Whole-Exome Sequencing Revealed Mutations of MED12 and EFNB1 in Fetal Agenesis of the Corpus Callosum
por: Jiang, Ying, et al.
Publicado: (2019)

EFNB1 Acts as a Novel Prognosis Marker in Glioblastoma through Bioinformatics Methods and Experimental Validation
por: Shi, Yaohong, et al.
Publicado: (2021)

The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease
por: Chang, Ling-Sai, et al.
Publicado: (2016)

Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions
por: Xiong, Chiyi, et al.
Publicado: (2020)

Isolated Sagittal Synostosis in a Boy with Craniofrontonasal Dysplasia and a Novel EFNB1 Mutation
por: Chauhan, Bharesh K., et al.
Publicado: (2015)

Identification and expression analysis of a novel intragenic EFNB1 mutation causing craniofrontonasal syndrome()
por: Chacon-Camacho, Oscar F., et al.
Publicado: (2013)

Attention: Schizophrenia Risk Gene Product miR-137 Now Targeting EFNB2
por: Tooney, Paul A
Publicado: (2016)

Long-Term Hypermethylation of FcγR2B in Leukocytes of Patients with Kawasaki Disease
por: Chang, Ling-Sai, et al.
Publicado: (2021)

RNA-seq co-expression network analysis reveals anxiolytic behavior of mice with Efnb2 knockout in parvalbumin+ neurons
por: Sun, Ying, et al.
Publicado: (2021)

A Novel De Novo EFNB1 Gene Mutation in a Mexican Patient with Craniofrontonasal Syndrome
por: Ramirez-Garcia, M. A., et al.
Publicado: (2013)

Clinical and molecular characterization of craniofrontonasal syndrome: new symptoms and novel pathogenic variants in the EFNB1 gene
por: Bukowska-Olech, Ewelina, et al.
Publicado: (2021)

Upregulated EFNB2 and EPHB4 promotes lung development in a nitrofen-induced congenital diaphragmatic hernia rat model
por: Liu, Hao, et al.
Publicado: (2018)

MTHFR C677T Polymorphism and Risk of Congenital Heart Defects: Evidence from 29 Case-Control and TDT Studies
por: Wang, Wei, et al.
Publicado: (2013)

Tracheal separation is driven by NKX2-1-mediated repression of Efnb2 and regulation of endodermal cell sorting
por: Lewis, Ace E., et al.
Publicado: (2022)

Case report: Craniofrontonasal syndrome caused by a novel variant in the EFNB1 gene in a Colombian woman
por: Pachajoa, Harry, et al.
Publicado: (2023)

MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients
por: Wu, Shanshan, et al.
Publicado: (2016)

Duplication of the EFNB1 Gene in Familial Hypertelorism: Imbalance in Ephrin-B1 Expression and Abnormal Phenotypes in Humans and Mice
por: Babbs, Christian, et al.
Publicado: (2011)

Polymorphisms in the Angiogenesis-Related Genes EFNB2, MMP2 and JAG1 Are Associated with Survival of Colorectal Cancer Patients
por: Scherer, Dominique, et al.
Publicado: (2020)

A Genetic Variant rs1801274 in FCGR2A as a Potential Risk Marker for Kawasaki Disease: A Case-Control Study and Meta-Analysis
por: Duan, Jiayu, et al.
Publicado: (2014)

Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2
por: Li, Dapeng, et al.
Publicado: (2022)

Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics
por: Yang, Chunpeng, et al.
Publicado: (2018)

Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
por: Galeotti, Caroline, et al.
Publicado: (2016)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Editorial: Antibody Fc Engineering: Towards Better Therapeutics
por: Lei, Cheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a53k90jnteo28hpbj3enmc0kcu